238 related articles for article (PubMed ID: 25621410)
1. Lower limb lymphedema and neurological complications after lymphadenectomy for gynecological cancer.
Biglia N; Librino A; Ottino MC; Panuccio E; Daniele A; Chahin A
Int J Gynecol Cancer; 2015 Mar; 25(3):521-5. PubMed ID: 25621410
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study.
Kuroda K; Yamamoto Y; Yanagisawa M; Kawata A; Akiba N; Suzuki K; Naritaka K
BMC Womens Health; 2017 Jul; 17(1):50. PubMed ID: 28743274
[TBL] [Abstract][Full Text] [Related]
3. Frequency and risk factors of lower limb lymphedema following lymphadenectomy in patients with gynecological malignancies.
Graf N; Rufibach K; Schmidt AM; Fehr M; Fink D; Baege AC
Eur J Gynaecol Oncol; 2013; 34(1):23-7. PubMed ID: 23589994
[TBL] [Abstract][Full Text] [Related]
4. Complications of lymphadenectomy for gynecologic cancer.
Achouri A; Huchon C; Bats AS; Bensaid C; Nos C; Lécuru F
Eur J Surg Oncol; 2013 Jan; 39(1):81-6. PubMed ID: 23117018
[TBL] [Abstract][Full Text] [Related]
5. Use of lymphoscintigraphy to differentiate primary versus secondary lower extremity lymphedema after surgical lymphadenectomy: a retrospective analysis.
Roman MM; Barbieux R; Nogaret JM; Bourgeois P
World J Surg Oncol; 2018 Apr; 16(1):75. PubMed ID: 29631609
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, classification, and risk factors for postoperative lower extremity lymphedema in women with gynecologic malignancies: a retrospective study.
Hareyama H; Hada K; Goto K; Watanabe S; Hakoyama M; Oku K; Hayakashi Y; Hirayama E; Okuyama K
Int J Gynecol Cancer; 2015 May; 25(4):751-7. PubMed ID: 25723779
[TBL] [Abstract][Full Text] [Related]
7. [Postoperative administration of octreotide to reduce lymphorrhea, lymphocele, lymphedema and lymphatic ascites after lymphadenectomy in gynecological malignancies].
Weinberger V; Minář L; Felsinger M; Seidlová D; Ovesná P; Bednaříková M; Jandáková E; Rovný I
Ceska Gynekol; 2017; 82(2):92-99. PubMed ID: 28585840
[TBL] [Abstract][Full Text] [Related]
8. Lower-extremity lymphedema following management for endometrial and cervical cancer.
Mendivil AA; Rettenmaier MA; Abaid LN; Brown JV; Micha JP; Lopez KL; Goldstein BH
Surg Oncol; 2016 Sep; 25(3):200-4. PubMed ID: 27566023
[TBL] [Abstract][Full Text] [Related]
9. Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience.
Volpi L; Sozzi G; Capozzi VA; Ricco' M; Merisio C; Di Serio M; Chiantera V; Berretta R
Int J Gynecol Cancer; 2019 Feb; 29(2):312-319. PubMed ID: 30718312
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for lower-limb lymphedema after surgery for cervical cancer.
Ohba Y; Todo Y; Kobayashi N; Kaneuchi M; Watari H; Takeda M; Sudo S; Kudo M; Kato H; Sakuragi N
Int J Clin Oncol; 2011 Jun; 16(3):238-43. PubMed ID: 21213009
[TBL] [Abstract][Full Text] [Related]
11. Incidence and risk factors for lower limb lymphedema after gynecologic cancer surgery with initiation of periodic complex decongestive physiotherapy.
Deura I; Shimada M; Hirashita K; Sugimura M; Sato S; Sato S; Oishi T; Itamochi H; Harada T; Kigawa J
Int J Clin Oncol; 2015 Jun; 20(3):556-60. PubMed ID: 24993674
[TBL] [Abstract][Full Text] [Related]
12. Comparison of lymphedema incidence between 2 lymphadenectomy techniques in patients with uterine cancer undergoing robotic staging.
Menderes G; Azodi M; Schwartz P; Silasi DA
Int J Gynecol Cancer; 2015 Jan; 25(1):160-5. PubMed ID: 25386859
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of lower-extremity lymphedema after radical surgery with or without adjuvant radiotherapy in patients with FIGO stage I to stage IIA cervical cancer.
Kim JH; Choi JH; Ki EY; Lee SJ; Yoon JH; Lee KH; Park TC; Park JS; Bae SN; Hur SY
Int J Gynecol Cancer; 2012 May; 22(4):686-91. PubMed ID: 22398707
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy negates the effect of retroperitoneal nonclosure for prevention of lymphedema of the legs following pelvic lymphadenectomy for gynecological malignancies: an analysis from a questionnaire survey.
Tanaka T; Ohki N; Kojima A; Maeno Y; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Sasaki H; Nishimura R
Int J Gynecol Cancer; 2007; 17(2):460-4. PubMed ID: 17316358
[TBL] [Abstract][Full Text] [Related]
15. Current Status and Progress in the Treatment of Lower Limb Lymphedema After Treatment of Gynecological Oncology.
Zhang H; Kong W; Han C; Liu T; Li J; Song D
Lymphat Res Biol; 2022 Jun; 20(3):308-314. PubMed ID: 34698556
[No Abstract] [Full Text] [Related]
16. Risk factors for late-onset lower limb lymphedema after gynecological cancer treatment: A multi-institutional retrospective study.
Yoshihara M; Shimono R; Tsuru S; Kitamura K; Sakuda H; Oguchi H; Hirota A
Eur J Surg Oncol; 2020 Jul; 46(7):1334-1338. PubMed ID: 32146054
[TBL] [Abstract][Full Text] [Related]
17. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
Rebegea L; Firescu D; Dumitru M; Anghel R
Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
[TBL] [Abstract][Full Text] [Related]
18. Identifying risk factors for occult lower extremity lymphedema using computed tomography in patients undergoing lymphadenectomy for gynecologic cancers.
Kim M; Suh DH; Yang EJ; Lim MC; Choi JY; Kim K; No JH; Kim YB
Gynecol Oncol; 2017 Jan; 144(1):153-158. PubMed ID: 28094037
[TBL] [Abstract][Full Text] [Related]
19. Incidence of lymphedema in the lower limbs and lymphocyst formation within one year of surgery for endometrial cancer: A prospective longitudinal multicenter study.
Wedin M; Stålberg K; Marcickiewicz J; Ahlner E; Åkesson Å; Lindahl G; Kjølhede P;
Gynecol Oncol; 2020 Oct; 159(1):201-208. PubMed ID: 32763108
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with response to compression-based physical therapy for secondary lower limb lymphedema after gynecologic cancer treatment: a multicenter retrospective study.
Yoshihara M; Kitamura K; Tsuru S; Shimono R; Sakuda H; Mayama M; Tano S; Uno K; Ukai MO; Kishigami Y; Oguchi H; Hirota A
BMC Cancer; 2022 Jan; 22(1):25. PubMed ID: 34980013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
